Belvas en es it fr

Belvas Brand names, Belvas Analogs

Belvas Brand Names Mixture

  • No information avaliable

Belvas Chemical_Formula

C24H36O5

Belvas RX_link

http://www.rxlist.com/cgi/generic3/altocor.htm

Belvas fda sheet

Belvas FDA

Belvas msds (material safety sheet)

Belvas Synthesis Reference

R. L. Monaghan et al., U.S. Pat. 4,231,938 (1980)

Belvas Molecular Weight

404.54 g/mol

Belvas Melting Point

174.5 oC

Belvas H2O Solubility

0.0004 mg/mL

Belvas State

Solid

Belvas LogP

4

Belvas Dosage Forms

Tablet

Belvas Indication

For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart disease

Belvas Pharmacology

Lovastatin, an antilipemic agent produced by fermentation of Aspergillus terreus, is the first of a class of lipid-lowering agents known as the HMG-CoA reductase inhibitors. Lovastatin is used to treat hypercholesterolemia, to slow coronary atherosclerosis, and to prevent myocardial infarction and stroke. Lovastatin, like simvastin and unlike pravastatin, is a prodrug, concentrating active drug in the liver during first-pass circulation.

Belvas Absorption

30%

Belvas side effects and Toxicity

LD50>1000 mg/kg (orally in mice)

Belvas Patient Information

PATIENT INFORMATION

Lovastatin is used to lower high cholesterol levels. This medication should
not be taken if you are pregnant, nursing, or have liver disease. Lovastatin
should be taken with the evening meal. This medication may cause increased
sensitivity to sunlight. Use sunscreens and wear protective clothing until
degree of sensitivity is determined. Notify your physician if you develop
blurred vision; skin rash; muscle pain, weakness, or cramps; unexplained fever,
or yellowing of the skin or eyes.

Patients should be advised about substances they should not take concomitantly
with lovastatin and be advised to report promptly unexplained muscle pain,
tenderness, or weakness (see list below and WARNINGS, Myopathy/Rhabdomyolysis ).
Patients should also be advised to inform other physicians prescribing a new
medication that they are taking MEVACOR .

Belvas Organisms Affected

Humans and other mammals